文献速递腹部USMR

二维剪切波弹性成像测量肝脏硬度:脂肪变性对纤维化评估的影响

Liver Stiffness Measurements by 2D Shear-Wave Elastography: Effect of Steatosis on Fibrosis Evaluation.
PubMed 文献 · AJR Am J Roentgenol · 2022-05-04

本回顾性研究纳入888例慢性肝病患者,以MR弹性成像测得的肝硬度为参考标准,评估二维剪切波弹性成像测得的肝硬度在诊断肝纤维化时是否受肝脂肪变性影响。结果显示,在F0和F1纤维化患者中,重度脂肪变性者的二维剪切波弹性成像肝硬度值显著高于无脂肪变性者,降低了纤维化检测的特异度。作者认为,联合超声衰减参数评估有助于识别需谨慎解读二维剪切波弹性成像肝硬度值的患者。

要点

  • 在F0纤维化患者中,MRI质子密度脂肪分数诊断的重度脂肪变性者二维剪切波弹性成像肝硬度值显著高于无脂肪变性者。
  • 重度脂肪变性可导致无或轻度脂肪变性患者二维剪切波弹性成像肝硬度值高估,降低纤维化检测特异度。
  • 联合评估超声衰减参数可能有助于识别需谨慎解读二维剪切波弹性成像肝硬度值的患者。

核心结论

  • 重度肝脂肪变性可能导致无或轻度脂肪变性患者的二维剪切波弹性成像肝硬度值高估,降低肝纤维化检测的特异度。

研究设计与样本

  • 回顾性研究,纳入888例慢性肝病患者(442例女性,446例男性;中位年龄67岁),在3个月窗口内同时接受二维剪切波弹性成像和MR弹性成像检查。

关键影像表现/征象

  • 在MRI质子密度脂肪分数诊断的F0纤维化患者中,重度脂肪变性者二维剪切波弹性成像肝硬度值为5.5 kPa(IQR 4.7-6.0 kPa),无脂肪变性者为4.7 kPa(IQR 4.2-5.5 kPa),p=.009。
  • 在MRI质子密度脂肪分数诊断的F1纤维化患者中,重度脂肪变性者二维剪切波弹性成像肝硬度值为6.3 kPa(IQR 6.0-7.2 kPa),无脂肪变性者为5.9 kPa(IQR 5.0-6.6 kPa),p=.009。
  • 在超声衰减参数诊断的F1纤维化患者中,重度脂肪变性者二维剪切波弹性成像肝硬度值为6.6 kPa(IQR 5.9-7.3 kPa),无脂肪变性者为5.9 kPa(IQR 5.1-6.5 kPa),p=.008。
  • 在给定纤维化分期下,二维剪切波弹性成像肝硬度值在其他脂肪变性分级间无显著差异(所有p>.05)。

诊断标准与关键数值

  • 以MR弹性成像肝硬度为参考标准,MRI质子密度脂肪分数诊断无脂肪变性者检测≥F1纤维化的敏感度为63.8%、特异度为91.5%,重度脂肪变性者为60.4%和80.9%。
  • 以MR弹性成像肝硬度为参考标准,超声衰减参数诊断无脂肪变性者检测≥F1纤维化的敏感度为62.4%、特异度为91.5%,重度脂肪变性者为72.1%和78.3%。
  • 纤维化分期和脂肪变性分级根据先前已建立的阈值进行分类。

临床应用与阅片要点

  • 在二维剪切波弹性成像检查中评估超声衰减参数,可能有助于识别需谨慎解读肝硬度值的患者。
  • 对于二维剪切波弹性成像提示无或轻度脂肪变性而超声衰减参数提示重度脂肪变性的患者,MR弹性成像有助于提供更可靠的肝纤维化测量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Hepatic steatosis has been found not to affect liver stiffness measurements (LSM) from MR elastography (MRE). However, the effect of steatosis on LSM from 2D shear-wave elastography (SWE) remains controversial. OBJECTIVE. The purpose of this study was to evaluate the effect of hepatic steatosis on the diagnostic performance of LSM from 2D SWE (LSM2D SWE) for evaluation of liver fibrosis with LSM from MRE (LSMMRE) as the reference standard. METHODS. This retrospective study included 888 patients (442 women, 446 men; median age, 67 years) with chronic liver disease who underwent LSM by both 2D SWE and MRE within a 3-month window. Steatosis was also assessed on ultrasound examinations by ultrasound-guided attenuation parameter (UGAP) and on MRI examinations by proton density fat fraction (PDFF). Fibrosis stages and steatosis grades were classified according to previously established thresholds. The effect of steatosis on LSM2D SWE was evaluated by Kruskal-Wallis tests with post hoc tests and ROC analysis. RESULTS. LSM2D SWE were significantly higher in patients with severe steatosis than those without steatosis by MRI PDFF among patients with F0 fibrosis (5.5 kPa [IQR, 4.7-6.0 kPa] vs 4.7 kPa [IQR, 4.2-5.5 kPa], p = .009) and F1 fibrosis (6.3 kPa [IQR, 6.0-7.2 kPa] vs 5.9 kPa [IQR, 5.0-6.6 kPa], p = .009). LSM2D SWE were significantly higher in patients with severe steatosis than those without steatosis by UGAP among patients with F1 fibrosis (6.6 kPa [IQR, 5.9-7.3 kPa] vs 5.9 kPa [IQR, 5.1-6.5 kPa], p = .008). Otherwise, LSM2D SWE did not vary significantly across steatosis grades at a given fibrosis stage (all p > .05). Sensitivity and specificity for ≥ F1 fibrosis were 63.8% and 91.5% in patients without versus 60.4% and 80.9% in patients with severe steatosis by MRI PDFF and were 62.4% and 91.5% in patients without versus 72.1% and 78.3% in patients with severe steatosis by UGAP. CONCLUSION. Severe hepatic steatosis may result in overestimation of LSM2D SWE in patients without or with mild steatosis, reducing the specificity of liver fibrosis detection. CLINICAL IMPACT. Assessment of UGAP at 2D SWE may help identify patients in whom LSM2D SWE should be assessed with caution. In patients with no or mild steatosis by 2D SWE and severe steatosis by UGAP, MRE helps provide a more reliable measure of liver fibrosis.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Kumada T, Toyoda H, Yasuda S, et al. Liver Stiffness Measurements by 2D Shear-Wave Elastography: Effect of Steatosis on Fibrosis Evaluation. AJR Am J Roentgenol. 2022. PMID: 35506556. doi:10.2214/AJR.22.27656

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。